BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7083462)

  • 1. The role of VP16-213 (etoposide; NSC-141540) in gestational choriocarcinoma.
    Newlands ES; Bagshawe KD
    Cancer Chemother Pharmacol; 1982; 7(2-3):211-4. PubMed ID: 7083462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VP-16 in combinations for first-line treatment of malignant germ-cell tumors and gestational choriocarcinoma.
    Newlands ES
    Semin Oncol; 1985 Mar; 12(1 Suppl 2):37-41. PubMed ID: 2579442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumour activity of the epipodophyllin derivative VP16-213 (etoposide: NSC-141540) in gestational choriocarcinoma.
    Newlands ES; Bagshawe KD
    Eur J Cancer (1965); 1980 Mar; 16(3):401-5. PubMed ID: 6154579
    [No Abstract]   [Full Text] [Related]  

  • 4. Primary oral etoposide therapy in gestational trophoblastic disease. An update.
    Wong LC; Choo YC; Ma HK
    Cancer; 1986 Jul; 58(1):14-7. PubMed ID: 3011237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of etoposide in gestochoriocarcinoma.
    D'Incalci M; Sessa C; Rossi C; Roviaro G; Mangioni C
    Cancer Treat Rep; 1985 Jan; 69(1):69-72. PubMed ID: 2981622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anticancer effect of VP16-213 (etoposide) on three choriocarcinoma cell lines].
    Matsui H; Kobayashi O; Shirotake S; Sekiya S; Takamizawa H
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jun; 39(6):933-9. PubMed ID: 3611870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of oral VP16-213 as primary chemotherapeutic agent in treatment of gestational trophoblastic disease.
    Wong LC; Choo YC; Ma HK
    Am J Obstet Gynecol; 1984 Dec; 150(8):924-7. PubMed ID: 6095666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral etoposide for metastatic choriocarcinoma: a case report and review of guidelines.
    Breitbach GP; Sklavounos P; Veith C; Costa SD; Kuhn W; Solomayer EF; Juhasz-Boess I; Tempfer C
    Arch Gynecol Obstet; 2019 Apr; 299(4):1115-1119. PubMed ID: 30569343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ad-PUMA sensitizes drug-resistant choriocarcinoma cells to chemotherapeutic agents.
    Chen Y; Qian H; Wang H; Zhang X; Fu M; Liang X; Ma Y; Zhan Q; Lin C; Xiang Y
    Gynecol Oncol; 2007 Dec; 107(3):505-12. PubMed ID: 17884151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Basic and clinical study of anticancer effect of etoposide on choriocarcinoma].
    Fujii T; Maeda M
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 May; 40(5):593-600. PubMed ID: 3385278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Term delivery choriocarcinoma patient with brain and lung metastases successfully treated by etoposide, methotrexate, actomycin D, cyclophosphamide and vincristine (EMA-CO) chemotherapy.
    Hiramatsu Y; Masuyama H; Ishida M; Murakami K; Sakurai M
    Acta Med Okayama; 2005 Oct; 59(5):235-8. PubMed ID: 16286962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epipodophyllotoxin (VP16-213) in small cell carcinoma of the Bronchus resistant to initial combination chemotherapy.
    Harper PG; Dally MB; Geddes DM; Spiro SG; Smyth JF; Souhami RL
    Cancer Chemother Pharmacol; 1982; 7(2-3):179-80. PubMed ID: 6282480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uterine choriocarcinoma accompanied by an extremely high human chorionic gonadotropin level and thyrotoxicosis.
    Hsieh TY; Hsu KF; Kuo PL; Huang SC
    J Obstet Gynaecol Res; 2008 Apr; 34(2):274-8. PubMed ID: 18412797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxorubicin, Cyclophosphamide and VP16-213 (ACE) in the treatment of small cell lung cancer.
    Aisner J; Whitacre M; VanEcho DA; Wesley M; Wiernik PH
    Cancer Chemother Pharmacol; 1982; 7(2-3):187-93. PubMed ID: 6282482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New combination chemotherapy against drug-resistant choriocarcinoma].
    Matsui H; Kobayashi O; Takamizawa H
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jul; 39(7):1087-94. PubMed ID: 3611879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
    Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
    J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epipodophylin derivative (VP 16-23) in malignant teratomas and choriocarcinomas.
    Newlands ES; Bagshawe KD
    Lancet; 1977 Jul; 2(8028):87. PubMed ID: 69168
    [No Abstract]   [Full Text] [Related]  

  • 18. Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high-risk gestational trophoblastic disease.
    Schink JC; Singh DK; Rademaker AW; Miller DS; Lurain JR
    Obstet Gynecol; 1992 Nov; 80(5):817-20. PubMed ID: 1328977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-tumor and adverse effect of etoposide and cisplatin on human choriocarcinoma transplanted to nude mice--a correlation between effect and tissue distribution of the drugs].
    Adachi S; Yoshiya N; Misawa Y; Ishida M; Kanazawa K; Takeuchi S; Tanaka K
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Nov; 38(11):2031-6. PubMed ID: 3794452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment and prognosis of post term choriocarcinoma in The Netherlands.
    Lok CA; Ansink AC; Grootfaam D; van der Velden J; Verheijen RH; ten Kate-Booij MJ
    Gynecol Oncol; 2006 Nov; 103(2):698-702. PubMed ID: 16790263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.